• OPEN AN ACCOUNT
Indian Indices
Sensex
72,781.89 -251.89
( -0.34%)
Global Indices
Nasdaq
51,707.15 -164.40
(-0.32%)
Dow Jones
7,828.98 0.74
(0.01%)
Hang Seng
67,780.30 2.78
(0.00%)
Nikkei 225
10,730.66 80.33
(0.75%)
Forex
USD-INR
95.69 -0.76
(-0.79%)
EUR-INR
107.00 -1.04
(-0.96%)
GBP-INR
126.57 -1.05
(-0.82%)
JPY-INR
0.60 -0.01
(-0.89%)

EQUITY - MARKET SCREENER

5paisa Capital Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
540776
INE618L01018
141.9718886
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
5PAISA
37.02
1633.38
EPS(TTM)
Face Value()
Div & Yield %
9.41
10
0
 

InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.